Prelude Capital Management, LLC Standard Biotools Inc. Transaction History

Prelude Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $190,963 - $343,638	-48,468 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $136,795 - $217,115	25,100 Added 107.41%	48,468 $291,000
Q3 2020 Nov 16, 2020	BUY	$4.34 - $11.43 $101,417 - $267,096	23,368 New	23,368 $174,000
Q1 2020 May 15, 2020	SELL	$1.24 - $4.35 $1,140 - $4,001	-920 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $368 - $819	-160 Reduced 14.81%	920 $3,000
Q3 2019 Nov 14, 2019	SELL	$4.63 - $12.15 $116,523 - $305,779	-25,167 Reduced 95.89%	1,080 $5,000
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $284,205 - $350,494	24,735 Added 1635.91%	26,247 $323,000
Q1 2019 May 15, 2019	SELL	$8.47 - $14.36 $11,112 - $18,840	-1,312 Reduced 46.46%	1,512 $20,000
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $4,207 - $5,174	586 Added 26.18%	2,824 $24,000
Q3 2018 Nov 14, 2018	SELL	$5.92 - $8.35 $1,959 - $2,763	-331 Reduced 12.88%	2,238 $17,000
Q2 2018 Aug 14, 2018	SELL	$4.86 - $6.24 $10,410 - $13,366	-2,142 Reduced 45.47%	2,569 $15,000
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $11,149 - $15,453	1,939 Added 69.95%	4,711 $28,000
Q4 2017 Feb 14, 2018	SELL	$4.46 - $6.45 $12,590 - $18,208	-2,823 Reduced 50.46%	2,772 $16,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $19,862 - $30,716	5,595	5,595 $28,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.